The guidance may not apply in certain outbreak situations when more specific guidance may be needed. However, the recommendation in this guidance may still help reduce spread of various other types of infections. It should not replace specific guidance for viruses that transmit through the air and require special control measures, such as measles. As such, these are key examples we have highlighted, but the Respiratory Virus Guidance covers most common respiratory viral illnesses. We also have immunizations and treatments that help prevent severe outcomes of these viruses. Is there a plan to include others?ĬOVID-19, flu, and RSV are very common respiratory viruses that cause significant amounts of disease, especially in the fall/winter season. Why is the focus of the guidance on COVID-19, flu, and RSV? There are many respiratory viruses. Importantly, states (California, Oregon) and countries (Australia, Canada, Denmark, France, and Norway) that have changed their recommended isolation times have not seen increased hospitalizations or deaths related to COVID-19.ĬDC will continue to evaluate the available evidence, including public health and clinical trends, virology, behavioral science, and social practices, to ensure the recommendations in the guidance provide the intended protection. This updated guidance continues to protect those most at risk, and evidence indicates it will not significantly increase severe disease related to COVID-19 or other respiratory viruses. Flu, COVID-19, and RSV continue to be significant health burdens, especially to people at higher risk, and require ongoing actionable prevention strategies such as those recommended in our updated Respiratory Virus Guidance. Although COVID-19 is starting to look like other respiratory viruses like flu when we look at the number of hospitalizations and deaths, it continues to differ in important ways, such as Post-COVID Conditions. These viruses share similar routes of transmission, symptoms, and prevention strategies. Issuing Respiratory Virus Guidance brings a unified, practical approach to protecting against a range of common respiratory viral illnesses so that people can protect themselves and loved ones from these illnesses. As a result, this the right time to issue unified Respiratory Virus Guidance, rather than additional guidance for each specific virus. While still posing a significant health threat to those at higher risk, COVID-19 health impacts are now increasingly similar to other respiratory viruses, like flu, which are also important causes of illness and death, especially for people at higher risk. Complications like multisystem inflammatory syndrome in children (MIS-C) are now also less common, and prevalence of Long COVID is also going down.Last year, that number was around 76,000. In 2022, COVID-19 accounted for more than 245,000 deaths. Weekly hospital admissions for COVID-19 are down more than 75% from the peak of the initial Omicron wave in January 2022, and deaths are down by more than 90%.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |